H. Baurmann

3.1k total citations
61 papers, 1.2k citations indexed

About

H. Baurmann is a scholar working on Hematology, Ophthalmology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, H. Baurmann has authored 61 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Hematology, 15 papers in Ophthalmology and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in H. Baurmann's work include Acute Myeloid Leukemia Research (14 papers), Hematopoietic Stem Cell Transplantation (11 papers) and Chronic Myeloid Leukemia Treatments (8 papers). H. Baurmann is often cited by papers focused on Acute Myeloid Leukemia Research (14 papers), Hematopoietic Stem Cell Transplantation (11 papers) and Chronic Myeloid Leukemia Treatments (8 papers). H. Baurmann collaborates with scholars based in Germany, France and United States. H. Baurmann's co-authors include Rainer Schwerdtfeger, D. Huhn, W. Siegert, Michael Schleuning, Martin Bornhäuser, J. Beyer, Robert A. Zimmermann, Helmut Oettle, J. Zingsem and Carsten Bokemeyer and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

H. Baurmann

54 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
H. Baurmann Germany	18	757	294	215	211	180	61	1.2k
J. P. Jouet France	18	807 1.1×	194 0.7×	257 1.2×	220 1.0×	127 0.7×	34	1.1k
H. A. Messner Canada	20	660 0.9×	183 0.6×	287 1.3×	356 1.7×	242 1.3×	54	1.3k
Yukiko Tsunematsu Japan	22	425 0.6×	158 0.5×	182 0.8×	208 1.0×	409 2.3×	61	1.2k
Kazuko Hamamoto Japan	17	788 1.0×	345 1.2×	237 1.1×	138 0.7×	435 2.4×	47	1.2k
Keiko Yumura‐Yagi Japan	18	605 0.8×	383 1.3×	343 1.6×	332 1.6×	201 1.1×	49	1.2k
Ken Tabuchi Japan	19	1.1k 1.5×	465 1.6×	334 1.6×	296 1.4×	311 1.7×	52	1.5k
Tom Révész Netherlands	17	680 0.9×	259 0.9×	308 1.4×	139 0.7×	143 0.8×	33	997
RA Nash United States	17	948 1.3×	151 0.5×	521 2.4×	272 1.3×	130 0.7×	33	1.4k
Steven Neudorf United States	21	1.0k 1.3×	485 1.6×	265 1.2×	239 1.1×	256 1.4×	40	1.4k
DS Snyder United States	17	838 1.1×	334 1.1×	168 0.8×	368 1.7×	305 1.7×	29	1.5k

Countries citing papers authored by H. Baurmann

Since Specialization

Citations

This map shows the geographic impact of H. Baurmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Baurmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Baurmann more than expected).

Fields of papers citing papers by H. Baurmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Baurmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Baurmann. The network helps show where H. Baurmann may publish in the future.

Co-authorship network of co-authors of H. Baurmann

This figure shows the co-authorship network connecting the top 25 collaborators of H. Baurmann. A scholar is included among the top collaborators of H. Baurmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Baurmann. H. Baurmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jansen, Nicole, H. Baurmann, Gereon Lauer, et al.. (2022). Vaccines against the original strain of SARS-CoV-2 provide T cell memory to the B.1.1.529 variant. SHILAP Revista de lepidopterología. 2(1). 140–140. 3 indexed citations

Heinzelmann, Frank, Wolfgang Bethge, Dietrich W. Beelen, et al.. (2016). Allogeneic hematopoietic cell transplantation as curative therapy for non-transformed follicular lymphomas. Bone Marrow Transplantation. 51(5). 654–662. 5 indexed citations

Schmid, Christoph, Christian Koenecke, Bernd Hertenstein, et al.. (2015). Long-term results of adjuvant donor lymphocyte transfusion in AML after allogeneic stem cell transplantation. Bone Marrow Transplantation. 51(5). 663–667. 72 indexed citations

Stift, Judith, Hideo A. Baba, Elisabeth Huber, et al.. (2014). Consensus on the histopathological evaluation of liver biopsies from patients following allogeneic hematopoietic cell transplantation. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 464(2). 175–190. 17 indexed citations

Middeke, Jan Moritz, Dietrich W. Beelen, Michael Stadler, et al.. (2012). Outcome of high-risk acute myeloid leukemia after allogeneic hematopoietic cell transplantation: negative impact of abnl(17p) and −5/5q−. Blood. 120(12). 2521–2528. 42 indexed citations

Baurmann, H., Peter Bettelheim, Heinz Diem, W. Gaßmann, & Thomas Nebe. (2011). Lymphozytenmorphologie im Blutausstrich – Vorstellung einer überarbeiteten Nomenklatur und Systematik/Lymphocyte morphology in the peripheral blood film: proposal of a revised nomenclature and systematics. LaboratoriumsMedizin. 35(5). 261–270.

Gökbuget, Nicola, Nadežda Basara, H. Baurmann, et al.. (2011). High single-drug activity of nelarabine in relapsed T-lymphoblastic leukemia/lymphoma offers curative option with subsequent stem cell transplantation. Blood. 118(13). 3504–3511. 126 indexed citations

Bug, Gesine, et al.. (2010). Therapy of Sclerodermatous Chronic Graft-Versus-Host Disease with Mammalian Target of Rapamycin Inhibitors. Biology of Blood and Marrow Transplantation. 17(5). 657–663. 36 indexed citations

Baurmann, H., et al.. (2010). Allogeneic Hematopoietic Cell Transplantation For Myelofibrosis – Close Post-Transplant Surveillance Is Mandatory. Biology of Blood and Marrow Transplantation. 16(2). S289–S289. 1 indexed citations

10.

Erben, Philipp, Claudia Haferlach, Rainer Schwerdtfeger, et al.. (2009). “Clinical and Molecular Heterogeneity of Eosinophilia-Associated Myeloproliferative Neoplasms with a Translocation t(5;12)”.. Blood. 114(22). 4983–4983. 2 indexed citations

11.

Schleuning, Michael, et al.. (2008). Calcineurin inhibitor-free GVHD prophylaxis with sirolimus, mycophenolate mofetil and ATG in Allo-SCT for leukemia patients with high relapse risk: an observational cohort study. Bone Marrow Transplantation. 43(9). 717–723. 38 indexed citations

12.

Basara, Nadežda, H. Baurmann, Karin Kolbe, et al.. (2005). Antithymocyte globulin for the prevention of graft-versus-host disease after unrelated hematopoietic stem cell transplantation for acute myeloid leukemia: results from the multicenter German cooperative study group. Bone Marrow Transplantation. 35(10). 1011–1018. 80 indexed citations

13.

Naumann, Ralph, Torsten Zuberbier, Rainer Ordemann, et al.. (2001). Skin involvement as the first manifestation of systemic aspergillosis in patients after allogeneic hematopoietic cell transplantation. Bone Marrow Transplantation. 27(7). 753–755. 10 indexed citations

14.

Siegert, W., J. Beyer, D. Kingreen, et al.. (1998). Treatment of relapse after allogeneic bone marrow transplantation with unmanipulated G-CSF-mobilized peripheral blood stem cell preparation. Bone Marrow Transplantation. 22(6). 579–583. 19 indexed citations

15.

Siegert, W., J. Beyer, Imke Strohscheer, et al.. (1994). High-dose treatment with carboplatin, etoposide, and ifosfamide followed by autologous stem-cell transplantation in relapsed or refractory germ cell cancer: a phase I/II study. The German Testicular Cancer Cooperative Study Group.. Journal of Clinical Oncology. 12(6). 1223–1231. 167 indexed citations

16.

Caux, F., S. Aractingi, H. Baurmann, et al.. (1993). <i>Fusarium solani</i> Cutaneous Infection in a Neutropenic Patient. Dermatology. 186(3). 232–235. 19 indexed citations

17.

Baurmann, H., Tino F. Schwarz, Joachim Oertel, et al.. (1992). Acute parvovirus B19 infection mimicking myelodysplastic syndrome of the bone marrow. Annals of Hematology. 64(1). 43–45. 31 indexed citations

18.

Serke, Stefan, Tino F. Schwarz, H. Baurmann, et al.. (1991). Productive infection of in vitro generated haemopoietic progenitor cells from normal human adult peripheral blood with parvovirus B19: studies by morphology, immunocytochemistry, flow‐cytometry and DNA‐hybridization. British Journal of Haematology. 79(1). 6–13. 30 indexed citations

19.

Baurmann, H., F Ferchal, Antoine Gessain, et al.. (1988). Adult T-cell leukemia associated with HTLV-I and simultaneous infection by human immunodeficiency virus type 2 and human herpesvirus 6 in an African woman: A clinical, virologic, and familial serologic study. The American Journal of Medicine. 85(6). 853–857. 11 indexed citations

20.

Baurmann, H.. (1964). Zur nachbildfrage bei der entoptisch sichtbaren blutbewegung. Graefe s Archive for Clinical and Experimental Ophthalmology. 167(6). 564–572. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact